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Disclaimer 
The findings and conclusions in this report are those of the authors and do not necessarily reflect the 
official position of the Centers for Disease Control and Prevention. 
Precis: 
Deaths from stomach cancer have declined over the last century. Our results indicate that survival is low 
but improving, and there were no meaningful differences in survival between blacks and whites when all 
37 states were combined. Primary prevention through control of well-established risk factors could have 
the greatest impact on reducing the burden of stomach cancer. 
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stomach cancer, gastric cancer, CONCORD, population-based cancer survival, cancer registries, NPCR, 
SEER 
FUNDING SUPPORT: US Centers for Disease Control and Prevention (CDC; 12FED03123, 
ACO12036). 
CONFLICT OF INTEREST DISCLOSURES: None 
Author Contributions: 
Conceptualization: M Jim 
Methodology:  H Carreira 
Software: H Carreira 
Validation: H Carreira 
Formal analysis: H Carreira 
Investigation: H Carreira 
Resources: H Carreira 
Data curation: H Carreira 
Page 2 of 34Cancer
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
3 
Stomach cancer survival in the U.S. by race and stage 
 
Writing – original draft: M Jim 
Writing – review and editing: P Pinheiro, D Espey, C WIggins, H Weir 
Visualization: H Carreira 
Supervision: M Jim 
Project administration: H Weir 
 Funding acquisition: H Weir 
  
Page 3 of 34 Cancer
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
4 
Stomach cancer survival in the U.S. by race and stage 
 
 
Abstract 
Background: Stomach cancer was a leading cause of cancer-related deaths early in the twentieth 
century and has steadily declined over the last century in the United States. Even though incidence and 
death rates are now low, stomach cancer remains an important cause of morbidity and mortality in black, 
Asian and Pacific Islander, and American Indians and Alaska Native populations. 
Methods:  We used data from the CONCORD-2 study to analyze stomach cancer survival among males 
and females (15–99 years) diagnosed in 37 states covering 80% of the US population. We adjusted 
survival for background mortality using state- and race-specific (white and black) life tables, and age-
standardized using International Cancer Survival Standard weights. We present net survival up to five 
years by race (all, black, and white) for 2001–2003 and 2004–2009 to account for changes in collecting 
SEER Summary Stage 2000. 
Results:  Almost one-third of stomach cancers were diagnosed at a distant stage in both whites and 
blacks. Overall survival increased between 2001-2003 and 2004-2009 (26.1% and 29.0% respectively) 
with no differences seen by race. 1-, 3-, and 5-year survival was 53.1%, 33.8% and 29.0%. Survival 
improved in the majority of states. Survival by stage was 64.0% (local), 28.2% (regional) and 5.3% 
(distant).   
Conclusions: Our results indicate high fatality for stomach cancer, especially soon after diagnosis.  
Although improvements in stomach cancer survival were observed, survival remains relatively low for 
both blacks and whites. Primary prevention through control of well-established risk factors would be 
expected to have the greatest impact on further reducing deaths from stomach cancer. 
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Introduction 
Stomach cancer was a leading cancer cause of death early in the twentieth century in the United States 
(US).
1
  Both incidence and death rates for the disease declined steadily over the course of the last 
century in many high-income countries worldwide including the US.
2
 In the US, incidence and death 
rates are higher in blacks compared to whites.
3
  The causes of the decline are not fully understood but it 
has been postulated that the improved living conditions, the widespread use of refrigerators, the 
decreased consumption of salt- and smoked-preserved food, and the use of antibiotics that may eradicate 
Helicobacter pylori from the stomach mucosa, account for part of this decline.
4
 Even though incidence 
rates are now low in the US, stomach cancer remains an important cause of morbidity and mortality in 
blacks, Asians and Pacific Islanders (API), and American Indians and Alaska Natives (AI/AN) 
populations, with approximately 23,148 new cases and 11,261 new deaths from the disease expected in 
the US in 2013, representing approximately 1.5 percent of all malignant neoplasms.
3
 
 
The molecular biology of stomach cancer is complex and varies by site and histology. It is classified into 
several subsites within the stomach: cardia (roughly the top inch of the stomach), fundus, body, distal 
(antrum and pylorus), and lesser or greater curvature.
5
 It is stratified into two major histologic types: 
diffuse and intestinal.
4
 The incidence of gastric cardia cancer has remained stable or increased and is 
significantly higher among whites than blacks and among males, especially among whites, where the 
male-to-female ratio was 5:1.
5, 6
 Cardia carcinomas are highest among White males and lowest among 
females of all racial groups.
5
 They have poorer prognosis because proximal tumors are more difficult to 
remove.
7, 8
 Non-cardia incidence rates among blacks, API, and AI/AN were twice and triple those 
among whites
5
 but the incidence is dropping.
6, 9
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Stage of disease at diagnosis is an important predictor of prognosis.
10
  As with most cancers, cases 
diagnosed at early stage have more favorable survival than cases identified at distant stage.
11
 Stomach 
cancer symptomatology is non-specific and the vast majority of incident stomach cancer cases in the 
United States are diagnosed at distant stage.
12
  For this reason, incidence and mortality rates are closely 
aligned. 
 
Racial and ethnic differences in stomach cancer incidence and mortality rates have been well 
documented.
5, 13, 14
 Previous research has highlighted racial differences in survival within the US, with 
whites showing higher survival probabilities than blacks during 1988-2006.
15
    Differences in gastric 
cancer survival by country have also been observed.
10, 15, 16, 17
 The CONCORD-2 study established 
worldwide surveillance of cancer survival from 279 cancer registries in 67 countries with data from over 
25 million persons diagnosed with cancer.
17
 The CONCORD-2 study showed that five-year age-
standardized net survival from stomach cancer in the US was 29% in 2005-2009, having increased 7% 
since 1995-99.
17
 These estimates were calculated with combined data for all races and all stages. The 
objective of this paper was to use CONCORD-2 data to characterize black-white differences in stomach 
cancer survival in the US by state and by stage at diagnosis. This is the largest study to date, covering 
80% of the US population, thus benchmarking survival just prior to the implementation of the 
Affordable Care Act from 2010. 
 
Methods 
Data Source 
We used data from 37 state-wide cancer registries funded by either the CDC’s National Program of 
Cancer Registries (denoted by the dark color net survival bar in Figure 1) or the National Cancer 
Institute’s Surveillance, Epidemiology, and End Results (SEER) program (denoted by the pale color net 
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survival in Figure 1), or both (denoted by * in Figure 1).
18
 These registries participated in the 
CONCORD-2 study, 
17
 covered approximately 80% of the US population, and consented to inclusion of 
their data in the more detailed analyses reported here. We analyzed individual tumor records for adults 
(15-99 years) who were diagnosed with primary, invasive cancer of the stomach (International 
Classification of Diseases for Oncology (ICD-O): 
19
 C16.0-C16.6; C16.8-C16.9) during 2001-2009 and 
followed up to December 31, 2009. We included stomach cancers, regardless of whether the person had 
a previous cancer.  If a person was diagnosed with two or more cancers of the stomach during 2001 
through 2009, only the first was considered in the survival analyses.  
 
Patients were grouped by year of diagnosis into two calendar periods (2001-2003 and 2004-2009) to 
reflect changes in the methods used by US registries to collect data on stage at diagnosis. From 2001, 
most cancer registries coded stage directly from the source data to SEER Summary Stage 2000 
(SS2000).
20
 From 2004, all registries began to derive SS2000 using the Collaborative Stage System.
21
  
 
Statistical Analyses 
We estimated net survival up to 5 years after diagnosis, with 95% confidence intervals (CI), using the 
Pohar Perme estimator.
22
 We analyzed survival by black and white race, stage at diagnosis, calendar 
period of diagnosis, and state.  Net survival is the probability of survival up to a given time since 
diagnosis, after controlling for other causes of death (background mortality). To control for wide 
differences in background mortality among participating states, we constructed life tables of all-cause 
mortality in the general population of each state from the number of deaths and the population, by single 
year of age, calendar year and race (black, white), using a flexible Poisson model.
23
 The life tables have 
been published.
24
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We estimated net survival using the cohort approach for patients diagnosed in 2001-2003, since all 
patients had been followed up for at least five years by December 31, 2009. We used the complete 
approach to estimate net survival for patients diagnosed from 2004-2009, because five years of follow-
up data were not available for all patients. Net survival was estimated for five age-groups (15-44, 45-54, 
55-64, 65-74, 75-99 years). We obtained age-standardized survival estimates using the International 
Cancer Survival Standard (ICSS) weights.
25
 If two or more of the five age-specific estimates could not 
be obtained, we present only the pooled, unstandardized survival estimate for all ages combined.  
 
Trends, geographic variations and differences in age-standardized survival by race are presented 
graphically in bar-charts and funnel plots.
26
 Funnel plots are graphical representations designed to detect 
excessive variation in performance indicators by simple visual inspection of the data.
27
 A funnel plot 
comprises four elements
26
: the target (or reference) value for the outcome, a set of control limits (the 
funnel), data points for the outcome variable (indicator) and the associated precision parameter for each 
data point. Data points outside the control limits (the funnel) indicate variation in the indicator beyond 
what would be expected by chance, while taking account of precision.
27
 Funnel plots of net survival for 
2001-2003 and 2004-2009 provide insight into the variability of cancer survival in the US by race and 
state. They show how much a particular survival estimate deviates from the pooled estimate of US 
registries (horizontal line) given the precision of each estimate. 
More details on data and methods are provided in the accompanying article by Allemani et al. 2017.
28
 
 
Results 
We present the overall results for stomach cancer in the participating 37 registries in Tables 1, 2, and 3.  
Results by state are presented in Supplementary Tables 1, 2 and 3.  A total of 150,700 stomach cancer 
cases were diagnosed in the study population between 2001 and 2009: 76.2% were diagnosed in whites 
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and 15.4% were diagnosed in blacks (Table 1).  Overall for 2004-2009, 30.8% of cases were distant 
stage, 28.8% were regional, 24.9% were localized, and the remaining cases (15.4%) were of unknown 
stage. Differences in proportions of each stage by race in 2004-2009 were 1% or less.   Case counts by 
state over the 9-year period, shown in Supplementary table 1, ranged from a minimum of 227 
(Wyoming) to a maximum of 23,247 (California).    
 
The absolute change in five-year age-standardized net survival across between 2001-2003 and 2004-
2009 by geographic region and state are shown in Figure 1. For all states combined, there was an 
increase of 2.9% in five-year net survival between these two periods. Although a net favorable 
difference between 2001-2003 and 2004-2009 was observed, the combined 37-state five-year net 
survival was low for both periods (26.1% and 29.0% respectively) (Figure 1). For 29 of the states, 
survival increased between the two periods. 
 
Overall 1-, 3-, and 5-year survival in 2004-2009 was 53.1%, 33.8% and 29.0%, demonstrating high 
mortality for stomach cancer, especially soon after diagnosis (Table 2). There were no meaningful 
differences in survival between blacks and whites when all 37 states were combined. Some states 
showed substantial in-state differences between blacks and whites; however, there were no discernible 
geographical patterns to the differences (Supplementary Table 2). Five-year net survival improvement 
by race from the first to second period was 3.1 percent points for whites and 2.2 for blacks resulting in a 
slight deviation in survival between groups over time. The deviation seen at five-year net survival 
between whites and blacks indicate that there could be no differences in short-term survival but 
differences between races could widen over time. 
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Five-year net survival by stage (Table 3) for 2004-2009 was 64.0%, 28.2% and 5.3% for localized, 
regional and distant stages, respectively. Improvements in five-year net survival by stage of diagnosis 
were observed between the two periods for both whites and blacks. At the localized stage, there were no 
racial differences in survival, and increases of 3.0% were seen for both races.  At the regional stage, 
survival increased by 3.4% among whites, but only by 1.3% among blacks. At the distant stage, the 
increase between the two periods was 0.5% for whites and 1.0% for blacks. While blacks experienced 
lower survival than whites when diagnosed at the regional stage, this is not the case at the distant stage, 
where whites experienced lower survival than blacks. Five-year survival was uniformly low across all 
states (Supplementary table 3).  
 
Funnel plots were used to show state- and race-specific 5-year age-standardized stomach cancer survival 
in relation to the precision of the survival estimate. The pooled (US) survival estimates for each calendar 
period (26.1% and 29.0%, respectively) are shown by the horizontal (solid) line in Figure 2. The 95.0% 
and 99.8% control limits (dotted lines) show the precision of the US estimate if the US estimate was 
based on varying case counts.  Five-year age-standardized net survival was similar for whites (open 
circles) and blacks (closed circles) for 2001-2003. For the 2004-2009 period, similar patterns were 
observed although the aggregates tended to be less clustered, with larger survival differences especially 
among white populations in more populous states (right side of the figure). The pooled net survival did 
improve slightly between 2001-2003 and 2004-2009, as shown by the solid lines. There appears to be no 
overall difference in stomach cancer survival between whites and blacks.  
 
Discussion 
Stomach cancer incidence and mortality have been falling in the US for decades.
2
 Yet despite these 
favorable trends, survival has remained poor.
4, 11, 29
 This study provides the most comprehensive and 
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current profile of stomach cancer survival patterns in the US, which may be useful to public health and 
medical communities focused on stomach cancer research and control efforts. Our findings suggest that 
there has only been very modest improvement in stomach cancer survival in recent years. Furthermore, 
unlike for other cancers included in the CONCORD-2 study, we did not observe a difference in survival 
or stage at diagnosis between whites and blacks. Unfortunately, examination of gender, anatomic 
subsite, and histology were outside the scope of this report, and this may partly explain the lack of 
survival disparity observed between blacks and whites. 
 
Incidence and mortality trends for stomach cancer can inform whether modest improvements in stomach 
cancer represent true progress. Racial and ethnic differences in the incidence and mortality for stomach 
cancer exist, with rates greater in males than females.
14, 30
 United States Cancer Statistics estimates that 
incidence rates are 1.7 times higher in blacks than whites and mortality rates are 2.0 times higher in 
blacks than in whites.
3
 SEER data show that the stomach cancer burden in the population has been 
decreasing in the US.
14, 31
 The National Center for Health Statistics mortality trend from 1984 to 2008 
consistently declined by 30-40% in all racial or race-sex groups, with differences in mortality getting 
smaller.
31
 SEER incidence trends from 1974-1978 to 2004-2008 showed a steady decline in all racial or 
race-sex groups that was consistent with the decline in mortality.
31
 An increased incidence among young 
white populations in the US has also been observed in SEER data
9
 but requires further exploration. The 
reductions in death rates from stomach cancer parallel a reduction in incidence rates and suggests true 
progress in the primary prevention of stomach cancer.  
 
Previous studies indicated that the decreases in stomach cancer incidence in the US may be attributed to 
declines in the distal (non-cardia) and intestinal type tumors.
5, 32
 The intestinal type at non-cardia sites is 
often found in males and older adults and the declining rates could be due to decreases in H. pylori 
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infection during childhood and the use of refrigeration to preserve foods instead of salt.
4, 7, 9, 33
  The 
higher rates of non-cardia carcinoma in blacks may reflect higher rates of H. pylori in this population.
30
 
The proximal, diffuse type tumors occur in all age groups and have been increasing in both males and 
females.
32, 33
 The diffuse type was consistently higher among blacks than whites.
5
 The diffuse type is 
harder to detect early, which results in poorer prognosis.
32
  If diffuse tumors increase as a proportion of 
the total tumors then it is possible that overall survival for gastric cancer will decrease. 
 
We examined the distribution of tumors by subsite. For all participating states combined, the distribution 
of cardia and non-cardia sites was 33.8% and 46.2% respectively for whites and 11.5% and 62.1% 
respectively for blacks (data not shown). Based on these distributions, it is likely that racial differences 
exist but are being masked by not examining survival by anatomic subsite. 
 
Despite stomach cancer’s poor prognosis, the increases in overall survival for all stages between the two 
periods are positive, especially given that there was an increase in the proportion of the worse prognosis 
types – cardia and diffuse – in the total pool of stomach cancer cases. The improvement in survival for 
each stage could be due to better therapy regimens or more access to appropriate treatment.
10, 34, 35
 
 
Some common risk factors for both cardia and non-cardia carcinoma of the stomach include alcohol 
consumption, foods preserved by salting, older age, male gender, tobacco smoking, race, family history, 
low physical activity, low fiber intake, and radiation.
4, 33
 Risk factors associated with cardia carcinomas 
include obesity and gastroesophageal reflux disease (GERD).
4, 33
 In 2011-2014, the prevalence of 
obesity among adults was just over 36% in adults and 17% in youth, and higher among females than 
males.
36
 From 1999-2000 through 2013-2014, a significant increase in obesity was observed in both 
adults and youth.
36
 With obesity on the rise and cardia tumors likely to increase with their worse 
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prognosis, the future burden of stomach cancer may increase.
37, 38
 Risk factors associated with non-
cardia carcinomas include infection with H. pylori, low socioeconomic status, consumption of processed 
meat, high intake of salty and smoked food, and low consumption of fruits and vegetables.
4, 33, 39-42
 
 
Overall in our study we observed an increase in survival between 2001-2003 and 2004-2009. The 
increase in survival that is observed could be related to the increase in locally staged cancers, however 
the bulk of stomach cancers are diagnosed in distant stage, and that proportion is increasing according to 
data in Table 1, at the expense of regional and unknown stages. The increase in locally staged cancer 
could be related to heightened awareness in the clinical community. More studies are needed to 
understand why survival is increasing despite the absence of improving stage distribution and decreasing 
trend for sub-categories of good prognosis. 
                            
Clinical Perspective 
 
Stomach cancer symptomology is non-specific and as a result most patients often present at an advanced 
stage. Diagnosis is by endoscopy and biopsy and CT scans of the chest, abdomen and pelvis are required 
to determine stage at diagnosis.
43
 Adjuvant chemotherapy and chemoradiotherapy after resection of 
stomach cancer offers survival benefits but the discrepancies between surgical technique and type of 
adjuvant chemotherapy used in clinical trials and survival probabilities has resulted in different adjuvant 
treatment protocols.
34
 The major challenge for clinicians is treatment sequence.
34
 New studies are 
needed to determine the best therapy. More effective therapy is needed as evidenced by the poor 
survival seen in our analyses. 
 
Cancer Control Perspective 
Page 13 of 34 Cancer
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
14 
Stomach cancer survival in the U.S. by race and stage 
 
 
Given the low stomach cancer survival observed in all states, cancer control efforts directed at primary 
prevention through control of well-established risk factors, such as smoking, maintaining a healthy 
weight, being physically active, eating a healthy diet (avoiding processed meat, and limiting salt intake), 
and limiting alcohol consumption may have an impact on reducing the burden of stomach cancer.
4, 33
 
Currently, there is inadequate evidence to support screening for stomach cancer.  
 
Strengths and Limitations 
 
Several limitations could impact the interpretation of the findings. First NPCR registries that participated 
in the CONCORD-2 study conducted linkage with their state vital records to obtain information on 
deaths that occurred within their state and with the CDC’s National Death Index to obtain information 
for deaths that occurred anywhere in the United States. Reliance on deaths reported by state vital records 
or the National Death Index may miss deaths that occur in patients who leave the United States between 
the time of their diagnosis and death. Therefore,  survival estimates for whites in Figure 2 in the states 
shown above the upper limit of the US survival estimate in the second calendar period may need to be 
interpreted with caution because of issues related to follow-up. Missing deaths especially for foreign-
born blacks as well as for Hispanic whites, can impact the estimates.
28, 44-46
 Second, the manner in which 
SEER Summary Stage 2000 data were collected and reported changed for all registries in 2004.
17
 The 
impact of this change was most evident among NPCR-funded registries, where the percentage of cases 
with unknown stage decreased slightly beginning around 2004. Third, in addition to stage, stomach 
cancer survival is dependent upon anatomical site (cardia vs non-cardia) and histological type. Cancers 
located in the cardia or cancers of the diffuse Lauren histological type have a worse prognosis than non-
cardia and intestinal types, respectively. Moreover, the proportion of cardia tumors is higher among 
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white than black populations as indicated in our examination of the distribution of tumors by sub-site. In 
this study, survival by these tumor features were not analyzed; thus, comparisons across race require 
further study. Fourth, stomach cancer survival was not analyzed by sex for this paper, even though 
evidence does show that women are reported to have better survival from stomach cancer than men.
16, 47
 
Lastly, analyses of net survival by race were restricted to whites and blacks, the two major racial groups 
in the United States, because life tables for other races and Hispanics were not available. 
 
Conclusions 
Our results indicate that stomach cancer survival is low but appears to be increasing and is similar to the 
survival pattern seen in Europe.
29
 We did not see an apparent survival difference between blacks and 
whites but there appears to be a slight divergence between the groups over time. Primary prevention 
through control of well-established risk factors may be the most impactful action at this time. 
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Table 1. Stomach cancer: number of cases for adults (15-99 years) diagnosed 2001-2009 and distribution (%) by SEER Summary Stage 2000 (SS2000) at 
diagnosis, by race and calendar period of diagnosis. 
 2001-2003 2004-2009 
SS2000  All races White Black All races White Black 
No. of patients  49,225 38,036 7,332 101,475 76,800 15,906 
Localized (%) 22.1 22.2 21.2 24.9 24.8 24.6 
Regional  (%) 31.5 31.4 30.2 28.8 28.7 27.6 
Distant (%) 28.9 39.1 28.5 30.8 31.4 30.1 
Unknown (%) 17.5 17.3 20.1 15.4 15.1 17.7 
 
Table 2.  Stomach cancer: age-standardized net survival (NS %) at 1-, 3- and 5-years for adults (15-99 years) diagnosed 2001-2009, by race and calendar 
period of diagnosis. 
 2001-2003 2004-2009 
 All races White Black All races White Black 
Years NS 
(%)  
95% CI NS 
(%) 
95% CI NS 
(%) 
95% CI NS 
(%) 
95% CI NS 
(%) 
95% CI NS 
(%) 
95% CI 
1 49.1 48.7 - 49.6 48.6 48.1 - 49.1 46.9 45.7 - 48.1 53.1 52.7 - 53.4 52.5 52.1 - 52.9 50.9 50.1 - 51.8 
3 30.5 30.1 - 31.0 29.4 28.9 - 29.9 30.3 29.1 - 31.4 33.8 33.4 - 34.2 32.9 32.4 - 33.3 32.4 31.5 - 33.3 
5 26.1 25.7 - 26.6 24.9 24.4 - 25.4 26.1 25.0 - 27.3 29.0 28.6 - 29.5 28.0 27.5 - 28.5 28.3 27.1 - 29.4 
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Table 3.  Stomach cancer: 5-year age-standardized net survival (NS %) for adults (15-99 years) diagnosed 2001-2009, by SEER Summary Stage (SS2000) at 
diagnosis, race and calendar period of diagnosis. 
 2001-2003 2004-2009 
 All races White Black All races White Black 
SS2000 NS 
(%)  
 NS 
(%)  
 NS 
(%)  
 NS 
(%)  
 NS 
(%)  
 NS 
(%)  
 
All stages 26.1 25.7 - 26.6 24.9 24.4 - 25.4 26.1 25.0 - 27.3 29.0 28.6 - 29.5 28.0 27.5 - 28.5 28.3 27.1 - 29.4 
Localized 60.9 59.8 - 62.0 60.0 58.7 - 61.3 58.1 55.1 - 61.1 64.0 62.9 - 65.0 63.0 61.8 - 64.2 61.1 58.4 - 63.8 
Regional 25.2 24.4 - 26.0 23.5 22.6 - 24.4 27.0 24.9 - 29.1 28.2 27.4 - 29.0 26.9 26.0 - 27.9 28.3 26.0 - 30.5 
Distant 4.8 4.4 - 5.1 4.5 4.1 - 4.9 4.8 3.8 - 5.8 5.3 4.9 - 5.7 5.0 4.6 - 5.5 5.8 4.8 - 6.7 
Unknown 24.4 23.2 - 25.5 22.7 21.4 - 24.0 24.0 21.4 - 26.7 27.9 26.8 - 29.0 27.2 25.9 - 28.6 25.3 22.9 - 27.6 
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Figure legends: 
Figure 1.   Stomach cancer: 5-year age-standardized net survival (%) for adults (15-99 years) diagnosed during 2001-2003 and 2004-
2009, and absolute change (%): states grouped by U.S. Census Region. 
 
Note:  Data from 37 statewide cancer registries (covering 80.6% of the population) are ranked within U.S. Census Region by the 
survival estimate for 2004-2009. Dark colors denote states affiliated with the National Program of Cancer Registries (NPCR); pale 
colors denote states affiliated with the Surveillance, Epidemiology and End Results (SEER) Program; * denotes states affiliated with 
both federal surveillance programs.  Change (%) not plotted if a survival estimate was not available for one calendar period or one or 
more estimates was not age-standardized.  
 
Figure 2   Stomach cancer: 5-year age-standardized net survival (%) for adults (15-99 years), by state, race and calendar period of 
diagnosis.  
 
Note: The pooled (37 registries) survival estimate for each calendar period is shown by the horizontal (solid) line with corresponding 
95.0% and 99.8% control limits (dotted lines).   
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Supplementary Table 1.  Stomach: number of cases for adults (15-99 years) diagnosed 2001-2009 and distribution (%) by SEER Summary Stage 
2000 (SS2000) at diagnosis, by race, calendar period of diagnosis, and US Census Region and States. 
 
Note: NPCR indicates National Program of Cancer Registries; SEER indicates Surveillance, Epidemiology, and End Results program. Information 
on stage was not available for two states (Maryland and Wisconsin), or for Rhode Island for cases diagnosed during 2004- 2009.   
 
Supplementary Table 2.  Stomach cancer: age-standardized net survival (NS) (%) at 1-, 3- and 5-years for adults (15-99 years) diagnosed 2001-
2009, by race, calendar period of diagnosis, and US Census Region and States.  
 
Note: NPCR indicates National Program of Cancer Registries; SEER indicates Surveillance, Epidemiology, and End Results program. 
Unstandardized estimates are italicized.  
 
Supplementary Table 3.  Stomach cancer: 5-year age-standardized net survival (NS %) for adults  (15-99 years) diagnosed 2001-2009, by SEER 
Summary Stage 2000 at diagnosis, race, calendar period of diagnosis and US Census Region and States. 
 
Note: NPCR indicates National Program of Cancer Registries; SEER indicates Surveillance, Epidemiology, and End Results program. Information 
on stage was not available for two states (Maryland and Wisconsin), or for Rhode Island for cases diagnosed during 2004- 2009.   Unstandardized 
estimates are italicized.  
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Stage All races White Black All races White Black
UNITED STATES
No. of patients 49,225 38,036 7,332 101,475 76,800 15,906
Localized (%) 22.1 22.2 21.2 24.9 24.8 24.6
Regional (%) 31.5 31.4 30.2 28.8 28.7 27.6
Distant (%) 28.9 29.1 28.5 30.8 31.4 30.1
Unknown (%) 17.5 17.3 20.1 15.4 15.1 17.7
NORTHEAST
New England
Connecticut No. of patients 974 850 104 1,970 1,717 204
(SEER) Localized (%) 25.1 25.1 27.9 27.1 26.7 29.9
Regional (%) 34.0 34.7 27.9 32.0 31.8 30.4
Distant (%) 28.4 27.5 36.5 30.5 30.8 30.9
Unknown (%) 12.5 12.7 7.7 10.4 10.7 8.8
Massachusetts No. of patients 1,593 1,436 97 3,026 2,669 205
(NPCR) Localized (%) 22.2 22.3 22.7 25.8 26.2 22.4
Regional (%) 33.0 32.8 30.9 30.9 30.1 34.1
Distant (%) 31.5 31.0 37.1 32.2 32.4 35.1
Unknown (%) 13.2 13.9 9.3 11.1 11.2 8.3
New Hampshire No. of patients 209 201 - 472 457 -
(NPCR) Localized (%) 22.0 20.9 0.0 26.3 26.5 0.0
Regional (%) 32.5 32.8 100.0 29.7 29.5 75.0
Distant (%) 28.7 29.9 0.0 32.6 32.6 0.0
Unknown (%) 16.7 16.4 0.0 11.4 11.4 25.0
Rhode Island No. of patients 329 309 15 554 510 32
(NPCR) Localized (%) 22.8 22.3 40.0 - - -
Regional (%) 29.2 29.4 20.0 - - -
Distant (%) 33.7 33.7 26.7 - - -
Unknown (%) 14.3 14.6 13.3 - - -
Mid Atlantic
New Jersey No. of patients 2,452 1,944 348 4,737 3,688 701
(NPCR/SEER) Localized (%) 24.3 24.2 26.4 24.7 24.5 25.1
Regional (%) 32.9 32.7 34.2 30.8 31.1 28.5
Distant (%) 28.5 29.0 26.1 29.6 29.6 30.4
Unknown (%) 14.3 14.1 13.2 14.9 14.8 16.0
New York No. of patients 5,611 4,176 942 10,851 7,739 1,997
(NPCR) Localized (%) 21.1 21.3 20.3 25.4 25.0 24.2
Regional (%) 31.7 31.4 31.4 30.6 30.4 29.8
Distant (%) 25.8 25.8 26.0 30.0 30.5 31.9
Unknown (%) 21.5 21.5 22.3 14.0 14.2 14.0
Pennsylvania No. of patients 3,200 2,749 352 6,172 5,237 746
(NPCR) Localized (%) 21.3 21.3 20.2 25.3 24.8 28.2
Regional (%) 36.7 37.4 33.2 31.5 31.4 30.8
Distant (%) 28.2 27.7 30.7 31.9 32.5 29.1
Unknown (%) 13.9 13.6 15.9 11.4 11.3 11.9
SOUTH
South Atlantic
Delaware No. of patients 172 118 47 364 266 84
(NPCR) Localized (%) 27.3 28.0 27.7 22.8 20.7 29.8
Regional (%) 30.8 29.7 29.8 32.1 31.6 33.3
Distant (%) 30.8 32.2 29.8 34.3 35.3 33.3
Unknown (%) 11.0 10.2 12.8 10.7 12.4 3.6
Florida No. of patients 4,267 3,524 652 8,068 6,526 1,270
(NPCR) Localized (%) 20.4 20.4 20.1 23.8 23.7 24.0
Regional (%) 32.6 32.7 31.6 30.2 30.0 30.5
Distant (%) 27.8 27.4 30.8 28.6 28.6 29.7
Unknown (%) 19.2 19.5 17.5 17.4 17.7 15.8
Georgia No. of patients 1,408 804 554 3,157 1,804 1,229
(NPCR/SEER) Localized (%) 24.9 24.9 26.0 28.2 28.3 27.7
Regional (%) 32.2 32.0 31.6 29.9 29.2 30.4
Distant (%) 29.3 28.4 30.1 32.8 33.0 33.0
Unknown (%) 13.6 14.8 12.3 9.1 9.4 8.9
2001-2003 2004-2009
Table 1 – Stage distribution by state and race – Stomach Page 1 of 4 Produced 29 July 2016
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Stage All races White Black All races White Black
2001-2003 2004-2009
Maryland No. of patients 955 561 294 1,838 1,106 566
(NPCR) Localized (%) - - - - - -
Regional (%) - - - - - -
Distant (%) - - - - - -
Unknown (%) - - - - - -
North Carolina No. of patients 1,449 977 426 3,222 2,142 957
(NPCR) Localized (%) 25.1 25.9 23.5 26.9 27.7 25.4
Regional (%) 29.9 29.8 29.1 29.3 29.6 28.3
Distant (%) 31.6 30.8 34.0 31.2 31.0 31.7
Unknown (%) 13.4 13.5 13.4 12.7 11.7 14.6
South Carolina No. of patients 877 494 364 1,893 1,082 778
(NPCR) Localized (%) 22.3 22.9 21.7 28.8 31.8 25.3
Regional (%) 35.9 35.8 36.3 27.8 27.5 28.3
Distant (%) 26.9 26.7 26.9 29.7 28.9 30.2
Unknown (%) 14.8 14.6 15.1 13.7 11.7 16.2
West Virginia No. of patients 397 383 14 775 737 33
(NPCR) Localized (%) 25.9 25.6 35.7 25.2 25.6 18.2
Regional (%) 35.0 35.8 14.3 30.6 30.5 30.3
Distant (%) 22.9 23.2 14.3 28.9 28.5 33.3
Unknown (%) 16.1 15.4 35.7 15.4 15.3 18.2
East South Central
Alabama No. of patients 900 586 303 1,838 1,171 635
(NPCR) Localized (%) 25.8 27.8 21.5 32.4 35.1 27.2
Regional (%) 33.9 35.3 31.7 27.0 26.2 28.7
Distant (%) 26.9 24.7 31.4 28.2 27.3 30.2
Unknown (%) 13.4 12.1 15.5 12.3 11.4 13.9
Kentucky No. of patients 729 655 71 1,548 1,387 132
(NPCR/SEER) Localized (%) 26.7 27.3 21.1 29.7 29.7 28.0
Regional (%) 30.5 29.6 36.6 27.8 28.1 25.8
Distant (%) 26.2 26.7 22.5 29.5 29.1 34.8
Unknown (%) 16.6 16.3 19.7 13.0 13.0 11.4
Mississippi No. of patients 193 110 82 1,210 623 566
(NPCR) Localized (%) 32.6 40.9 22.0 25.4 26.2 24.0
Regional (%) 29.5 26.4 34.1 29.5 29.2 30.0
Distant (%) 20.2 16.4 25.6 28.2 28.9 27.7
Unknown (%) 17.6 16.4 18.3 16.9 15.7 18.2
Tennessee No. of patients 317 262 50 2,217 1,716 450
(NPCR) Localized (%) 26.8 27.5 24.0 29.2 30.3 24.9
Regional (%) 36.0 34.4 42.0 29.0 28.6 30.0
Distant (%) 22.1 23.7 16.0 27.2 27.3 27.6
Unknown (%) 15.1 14.5 18.0 14.6 13.9 17.6
West South Central
Louisiana No. of patients 1,037 578 441 2,123 1,159 933
(NPCR/SEER) Localized (%) 24.9 25.8 24.3 30.4 33.0 27.8
Regional (%) 31.9 29.1 34.2 27.2 24.9 29.3
Distant (%) 28.3 30.1 26.5 31.5 31.2 32.2
Unknown (%) 14.9 15.1 15.0 10.9 10.8 10.8
Oklahoma No. of patients 631 493 60 1,248 943 126
(NPCR) Localized (%) 25.8 26.8 26.7 27.5 27.7 33.3
Regional (%) 28.4 27.4 30.0 25.5 25.2 26.2
Distant (%) 28.4 28.4 23.3 28.0 27.9 21.4
Unknown (%) 17.4 17.4 20.0 19.1 19.2 19.0
Texas No. of patients 3,911 3,182 592 8,411 6,748 1,260
(NPCR) Localized (%) 20.2 20.3 18.6 24.5 24.5 24.7
Regional (%) 31.8 31.9 32.6 28.0 28.2 26.3
Distant (%) 29.4 29.4 30.1 31.9 32.0 32.9
Unknown (%) 18.6 18.5 18.8 15.6 15.2 16.2
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MIDWEST
East North Central
Michigan No. of patients 2,099 1,628 426 4,193 3,236 799
(NPCR/SEER) Localized (%) 24.5 24.4 25.1 25.0 24.7 25.8
Regional (%) 29.5 30.2 26.3 25.9 26.8 23.7
Distant (%) 27.9 27.6 30.3 27.1 27.1 26.9
Unknown (%) 18.1 17.8 18.3 22.0 21.4 23.7
Ohio No. of patients 2,174 1,756 351 4,511 3,718 667
(NPCR) Localized (%) 20.7 20.4 19.4 21.6 21.3 22.3
Regional (%) 29.3 29.4 29.1 28.8 29.2 28.0
Distant (%) 25.3 25.4 27.4 30.5 30.8 30.0
Unknown (%) 24.7 24.7 24.2 19.2 18.7 19.6
Wisconsin No. of patients 890 820 41 1,587 1,423 110
(NPCR) Localized (%) - - - - - -
Regional (%) - - - - - -
Distant (%) - - - - - -
Unknown (%) - - - - - -
West North Central
Iowa No. of patients 531 503 15 1,123 1,081 26
(SEER) Localized (%) 23.2 22.5 33.3 26.4 26.7 15.4
Regional (%) 25.8 25.8 26.7 27.2 26.9 38.5
Distant (%) 37.5 38.4 33.3 37.2 37.1 38.5
Unknown (%) 13.6 13.3 6.7 9.2 9.3 7.7
Nebraska No. of patients 334 312 13 667 616 30
(NPCR) Localized (%) 21.6 21.8 30.8 18.7 19.5 6.7
Regional (%) 28.4 28.5 15.4 31.9 32.6 26.7
Distant (%) 30.2 30.4 38.5 33.6 33.0 36.7
Unknown (%) 19.8 19.2 15.4 15.7 14.9 30.0
WEST
Mountain
Colorado No. of patients 619 557 28 1,352 1,211 59
(NPCR) Localized (%) 22.9 23.2 25.0 20.5 19.7 27.1
Regional (%) 28.6 28.5 21.4 28.1 27.6 20.3
Distant (%) 31.5 31.2 46.4 38.7 39.5 44.1
Unknown (%) 17.0 17.1 7.1 12.7 13.2 8.5
Idaho No. of patients 204 197 - 403 378 -
(NPCR) Localized (%) 22.5 23.4 - 19.1 18.8 0.0
Regional (%) 36.3 35.0 - 28.5 28.6 100.0
Distant (%) 28.9 28.9 - 37.7 38.6 0.0
Unknown (%) 12.3 12.7 - 14.6 14.0 0.0
Montana No. of patients 201 190 - 332 299 -
(NPCR) Localized (%) 20.9 21.6 - 24.4 24.7 -
Regional (%) 37.8 36.3 - 31.6 32.1 -
Distant (%) 28.9 28.9 - 32.5 31.1 -
Unknown (%) 12.4 13.2 - 11.4 12.0 -
New Mexico No. of patients 356 305 - 865 746 18
(SEER) Localized (%) 26.1 26.9 40.0 33.5 33.9 55.6
Regional (%) 32.9 31.1 40.0 25.0 24.5 16.7
Distant (%) 30.9 31.5 0.0 30.1 29.5 22.2
Unknown (%) 10.1 10.5 20.0 11.4 12.1 5.6
Utah No. of patients 274 253 - 509 475 -
(SEER) Localized (%) 34.3 33.2 50.0 30.6 31.2 25.0
Regional (%) 24.8 24.5 50.0 24.0 22.7 0.0
Distant (%) 32.5 33.2 0.0 36.5 37.3 50.0
Unknown (%) 8.4 9.1 0.0 8.8 8.8 25.0
Wyoming No. of patients 68 67 - 159 155 -
(NPCR) Localized (%) 16.2 14.9 - 25.8 26.5 -
Regional (%) 30.9 31.3 - 27.0 25.8 -
Distant (%) 25.0 25.4 - 30.2 31.0 -
Unknown (%) 27.9 28.4 - 17.0 16.8 -
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Pacific
Alaska No. of patients 102 53 - 210 98 -
(NPCR) Localized (%) 19.6 17.0 0.0 23.8 22.4 50.0
Regional (%) 34.3 34.0 66.7 30.5 32.7 0.0
Distant (%) 32.4 30.2 33.3 33.8 28.6 0.0
Unknown (%) 13.7 18.9 0.0 11.9 16.3 50.0
California No. of patients 7,530 5,458 596 15,717 11,100 1,166
(NPCR/SEER) Localized (%) 21.1 20.6 19.3 24.9 23.8 25.5
Regional (%) 31.2 30.2 28.9 29.0 28.2 26.2
Distant (%) 35.8 37.1 36.2 35.3 37.3 35.8
Unknown (%) 11.8 12.0 15.6 10.9 10.7 12.6
Hawaii No. of patients 528 72 - 959 139 -
(SEER) Localized (%) 30.5 25.0 - 28.3 26.6 20.0
Regional (%) 37.7 37.5 - 31.2 28.1 20.0
Distant (%) 26.1 33.3 - 33.0 34.5 60.0
Unknown (%) 5.7 4.2 - 7.6 10.8 0.0
Oregon No. of patients 582 520 13 1,252 1,121 26
(NPCR) Localized (%) 18.4 17.5 15.4 25.2 25.8 23.1
Regional (%) 36.3 34.8 38.5 30.5 29.6 34.6
Distant (%) 32.3 34.0 30.8 32.9 33.3 30.8
Unknown (%) 13.1 13.7 15.4 11.4 11.3 11.5
Washington No. of patients 1,122 953 28 1,942 1,577 83
(NPCR/SEER) Localized (%) 24.5 24.8 14.3 23.0 21.9 32.5
Regional (%) 32.9 32.7 25.0 30.8 30.9 22.9
Distant (%) 31.4 30.8 53.6 37.8 38.6 32.5
Unknown (%) 11.2 11.6 7.1 8.3 8.6 12.0
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UNITED STATES
1 49.1 48.7 - 49.6 48.6 48.1 - 49.1 46.9 45.7 - 48.1 53.1 52.7 - 53.4 52.5 52.1 - 52.9 50.9 50.1 - 51.8
3 30.5 30.1 - 31.0 29.4 28.9 - 29.9 30.3 29.1 - 31.4 33.8 33.4 - 34.2 32.9 32.4 - 33.3 32.4 31.5 - 33.3
5 26.1 25.7 - 26.6 24.9 24.4 - 25.4 26.1 25.0 - 27.3 29.0 28.6 - 29.5 28.0 27.5 - 28.5 28.3 27.1 - 29.4
NORTHEAST
New England
Connecticut 1 55.7 52.3 - 59.1 55.6 51.9 - 59.3 50.4 41.3 - 59.5 59.1 56.7 - 61.5 59.2 56.6 - 61.7 54.3 47.5 - 61.0
(SEER) 3 35.7 32.3 - 39.2 35.6 31.9 - 39.3 27.9 19.5 - 36.4 38.4 35.7 - 41.2 37.8 34.9 - 40.8 36.4 28.9 - 43.9
5 30.7 27.2 - 34.2 30.3 26.6 - 34.1 23.0 14.9 - 31.1 32.3 29.0 - 35.5 31.2 27.7 - 34.6 34.6 26.7 - 42.5
Massachusetts 1 51.2 48.6 - 53.8 50.4 47.6 - 53.2 59.0 49.1 - 69.0 59.1 57.2 - 61.1 58.2 56.1 - 60.2 57.1 49.9 - 64.3
(NPCR) 3 33.6 31.0 - 36.2 33.1 30.4 - 35.9 37.9 27.7 - 48.1 39.7 37.4 - 41.9 38.8 36.4 - 41.2 37.1 29.3 - 44.8
5 29.3 26.7 - 31.9 28.9 26.1 - 31.7 34.8 24.5 - 45.1 35.6 32.9 - 38.2 34.9 32.1 - 37.8 29.6 21.5 - 37.8
New Hampshire 1 49.3 42.5 - 56.1 48.6 41.7 - 55.6 - 52.2 47.2 - 57.1 51.8 46.8 - 56.9 -
(NPCR) 3 26.2 20.0 - 32.4 25.5 19.3 - 31.7 - 33.4 28.2 - 38.5 32.0 26.8 - 37.3 -
5 21.7 15.8 - 27.6 20.8 14.9 - 26.7 - 29.9 24.0 - 35.8 28.6 22.7 - 34.6 -
Rhode Island 1 53.7 48.0 - 59.4 53.1 47.1 - 59.0 61.0 36.9 - 85.2 57.0 52.5 - 61.5 56.2 51.5 - 61.0 55.5 36.8 - 74.2
(NPCR) 3 32.0 26.3 - 37.6 31.9 26.0 - 37.8 42.0 17.2 - 66.8 38.4 33.4 - 43.4 37.1 31.8 - 42.3 42.5 23.2 - 61.9
5 27.5 21.9 - 33.1 27.7 21.8 - 33.5 29.4 6.3 - 52.5 31.3 25.3 - 37.3 30.8 24.6 - 37.0 34.7 13.7 - 55.7
Mid Atlantic
New Jersey 1 51.7 49.6 - 53.7 51.4 49.1 - 53.8 48.4 43.1 - 53.7 55.3 53.7 - 56.8 55.0 53.2 - 56.8 52.0 48.1 - 55.9
(NPCR/SEER) 3 32.7 30.7 - 34.8 31.5 29.2 - 33.8 32.4 27.2 - 37.7 35.4 33.7 - 37.1 34.6 32.6 - 36.6 31.7 27.4 - 35.9
5 27.9 25.9 - 30.0 26.7 24.4 - 29.0 27.2 21.9 - 32.6 29.3 27.2 - 31.4 28.9 26.5 - 31.3 25.4 20.3 - 30.5
New York 1 54.6 53.2 - 55.9 54.1 52.5 - 55.7 51.1 47.8 - 54.4 58.9 57.9 - 59.8 58.0 56.8 - 59.2 55.1 52.7 - 57.4
(NPCR) 3 35.2 33.9 - 36.6 33.5 31.9 - 35.1 34.9 31.6 - 38.2 39.5 38.4 - 40.7 37.9 36.5 - 39.3 36.6 34.1 - 39.2
5 30.6 29.2 - 31.9 28.4 26.8 - 30.0 30.9 27.6 - 34.2 34.6 33.2 - 36.0 32.3 30.6 - 34.0 32.6 29.5 - 35.6
Pennsylvania 1 48.4 46.5 - 50.3 48.7 46.7 - 50.7 46.0 40.6 - 51.5 53.2 51.9 - 54.6 52.8 51.3 - 54.3 53.3 49.4 - 57.1
(NPCR) 3 27.7 25.9 - 29.4 27.3 25.4 - 29.2 27.8 22.8 - 32.9 33.0 31.5 - 34.6 31.3 29.6 - 33.0 39.2 34.9 - 43.6
5 23.8 22.1 - 25.6 23.2 21.3 - 25.1 23.6 18.7 - 28.6 28.1 26.2 - 29.9 26.9 24.9 - 28.9 33.5 28.3 - 38.7
SOUTH
South Atlantic
Delaware 1 52.1 44.6 - 59.6 48.7 39.8 - 57.6 57.6 43.1 - 72.2 52.3 46.7 - 57.8 52.2 45.7 - 58.7 52.1 41.4 - 62.8
(NPCR) 3 35.0 27.5 - 42.5 34.3 25.7 - 42.8 34.4 19.2 - 49.6 32.1 26.5 - 37.7 32.3 25.9 - 38.8 28.7 18.0 - 39.4
5 30.7 23.1 - 38.2 30.0 21.6 - 38.5 28.4 12.7 - 44.1 28.8 22.6 - 34.9 28.4 21.6 - 35.1 28.0 13.4 - 42.6
Florida 1 51.7 50.1 - 53.3 51.8 50.0 - 53.5 50.5 46.5 - 54.5 55.6 54.5 - 56.8 55.5 54.2 - 56.8 54.9 51.9 - 57.8
(NPCR) 3 31.9 30.4 - 33.4 31.3 29.6 - 33.0 33.5 29.5 - 37.4 38.9 37.6 - 40.3 38.8 37.3 - 40.3 36.8 33.5 - 40.2
5 27.7 26.1 - 29.2 26.9 25.2 - 28.6 30.4 26.3 - 34.5 36.2 34.6 - 37.8 36.6 34.9 - 38.4 31.6 27.2 - 36.0
Georgia 1 46.8 44.1 - 49.4 47.9 44.3 - 51.4 44.6 40.3 - 48.9 50.3 48.4 - 52.2 50.7 48.2 - 53.2 49.1 46.1 - 52.2
(NPCR/SEER) 3 29.6 27.0 - 32.1 29.8 26.4 - 33.2 28.1 24.0 - 32.2 31.1 29.0 - 33.2 31.2 28.4 - 33.9 30.9 27.6 - 34.3
5 24.9 22.4 - 27.5 24.1 20.8 - 27.4 24.6 20.5 - 28.8 28.0 25.5 - 30.4 27.3 24.1 - 30.5 29.5 25.6 - 33.4
Maryland 1 46.5 43.2 - 49.7 45.2 40.9 - 49.5 41.6 35.9 - 47.4 52.7 50.2 - 55.2 52.2 49.0 - 55.4 49.3 44.9 - 53.7
(NPCR) 3 29.9 26.8 - 33.1 26.7 22.7 - 30.7 29.0 23.4 - 34.6 33.8 31.1 - 36.5 33.4 29.9 - 36.8 30.9 26.2 - 35.7
5 26.8 23.5 - 30.0 23.8 19.7 - 27.8 25.4 19.7 - 31.1 28.8 25.7 - 31.9 28.2 24.2 - 32.2 26.4 21.2 - 31.6
North Carolina 1 41.0 38.4 - 43.6 41.0 37.9 - 44.2 38.7 33.9 - 43.4 52.6 50.7 - 54.5 52.5 50.2 - 54.8 50.6 47.2 - 54.0
(NPCR) 3 29.0 26.5 - 31.5 28.5 25.4 - 31.5 27.4 22.8 - 32.0 33.2 31.1 - 35.2 33.6 31.0 - 36.2 30.4 26.7 - 34.1
5 25.6 23.0 - 28.1 25.1 22.1 - 28.2 23.8 19.2 - 28.4 29.2 26.7 - 31.7 29.0 25.9 - 32.1 27.8 23.7 - 31.9
South Carolina 1 48.8 45.4 - 52.2 49.9 45.4 - 54.4 45.8 40.6 - 51.0 51.6 49.1 - 54.0 53.8 50.6 - 57.0 48.7 44.9 - 52.4
(NPCR) 3 31.3 28.0 - 34.6 31.6 27.2 - 36.0 28.9 23.9 - 33.8 31.6 29.0 - 34.2 34.9 31.4 - 38.4 26.8 22.8 - 30.7
5 25.2 22.0 - 28.5 25.8 21.5 - 30.1 22.5 17.8 - 27.3 26.9 23.7 - 30.1 29.7 25.4 - 34.0 22.0 17.2 - 26.7
West Virginia 1 43.4 38.2 - 48.6 43.3 38.0 - 48.5 38.1 12.8 - 63.4 47.4 43.6 - 51.1 47.6 43.8 - 51.5 44.2 27.0 - 61.3
(NPCR) 3 24.6 19.9 - 29.3 24.5 19.7 - 29.2 23.7 2.3 - 45.0 28.3 24.4 - 32.1 28.3 24.4 - 32.3 30.1 13.1 - 47.1
5 20.8 16.2 - 25.4 20.5 15.8 - 25.1 23.7 2.3 - 45.0 22.8 18.4 - 27.1 22.9 18.4 - 27.3 23.8 4.5 - 43.0
East South Central
Alabama 1 46.9 43.6 - 50.3 45.3 41.1 - 49.4 50.0 44.3 - 55.8 50.7 48.2 - 53.1 52.1 49.0 - 55.1 47.0 42.8 - 51.2
(NPCR) 3 30.8 27.5 - 34.1 29.2 25.2 - 33.2 33.4 27.7 - 39.1 32.8 30.1 - 35.5 34.9 31.6 - 38.2 28.5 24.1 - 32.9
5 27.8 24.4 - 31.2 27.1 23.0 - 31.2 29.4 23.5 - 35.2 26.9 23.8 - 30.1 28.4 24.5 - 32.3 24.1 19.0 - 29.2
Kentucky 1 44.1 40.4 - 47.8 44.6 40.6 - 48.5 37.9 26.4 - 49.5 48.8 46.1 - 51.4 48.9 46.0 - 51.7 46.4 38.3 - 54.6
(NPCR/SEER) 3 25.2 21.8 - 28.6 25.6 22.0 - 29.2 21.7 11.3 - 32.0 30.0 27.1 - 32.9 29.7 26.7 - 32.8 32.3 24.0 - 40.6
5 20.7 17.4 - 24.1 21.1 17.6 - 24.6 15.9 5.9 - 25.9 27.8 24.5 - 31.2 27.6 24.1 - 31.1 31.3 23.0 - 39.6
Mississippi 1 57.8 50.9 - 64.7 61.7 53.1 - 70.2 55.0 45.4 - 64.6 48.6 45.6 - 51.6 48.8 44.6 - 53.1 47.6 43.2 - 52.0
(NPCR) 3 39.2 32.2 - 46.3 41.5 32.6 - 50.4 37.3 27.0 - 47.7 29.9 26.6 - 33.1 30.3 25.8 - 34.8 29.1 24.3 - 34.0
5 33.6 26.3 - 40.8 33.2 24.2 - 42.1 35.8 24.3 - 47.2 23.8 19.8 - 27.9 23.0 17.6 - 28.4 26.8 21.1 - 32.4
Tennessee 1 48.4 42.8 - 53.9 45.7 39.6 - 51.9 60.1 45.8 - 74.5 52.2 50.0 - 54.4 52.8 50.2 - 55.3 47.6 42.6 - 52.5
(NPCR) 3 27.4 22.3 - 32.6 24.4 19.0 - 29.9 39.1 24.2 - 54.1 33.9 31.4 - 36.4 34.7 31.9 - 37.5 29.3 23.9 - 34.7
5 22.4 17.5 - 27.3 19.5 14.4 - 24.6 31.8 15.6 - 48.0 29.7 26.8 - 32.6 30.8 27.6 - 34.1 24.1 17.9 - 30.3
West South Central
Louisiana 1 45.9 42.7 - 49.0 46.8 42.6 - 51.0 43.9 39.1 - 48.7 47.9 45.6 - 50.2 47.9 44.7 - 51.0 48.0 44.5 - 51.4
(NPCR/SEER) 3 29.8 26.8 - 32.9 29.7 25.6 - 33.8 29.1 24.5 - 33.7 29.3 26.8 - 31.7 30.6 27.2 - 33.9 28.3 24.6 - 32.0
5 25.3 22.2 - 28.3 24.5 20.5 - 28.6 24.9 20.4 - 29.5 24.9 22.1 - 27.8 26.3 22.3 - 30.2 23.9 19.9 - 27.9
95% CI95% CI 95% CI 95% CI 95% CI 95% CI
2001-2003 2004-2009
All races White Black All races White Black
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Oklahoma 1 41.5 37.5 - 45.5 40.8 36.2 - 45.4 46.3 33.3 - 59.2 46.8 43.8 - 49.7 48.3 44.9 - 51.7 50.8 41.6 - 60.1
(NPCR) 3 23.0 19.5 - 26.6 22.2 18.2 - 26.2 32.3 19.8 - 44.8 28.0 24.9 - 31.1 28.0 24.5 - 31.5 37.6 27.1 - 48.1
5 19.7 16.2 - 23.2 18.4 14.6 - 22.3 32.3 19.8 - 44.8 22.3 18.7 - 25.9 21.8 17.7 - 25.9 40.9 29.4 - 52.3
Texas 1 46.7 45.1 - 48.4 46.5 44.8 - 48.3 45.5 41.3 - 49.6 51.7 50.6 - 52.9 51.2 49.9 - 52.5 49.8 46.8 - 52.8
(NPCR) 3 29.7 28.2 - 31.3 29.3 27.6 - 31.0 29.6 25.5 - 33.6 32.4 31.1 - 33.7 31.5 30.1 - 32.9 31.6 28.4 - 34.8
5 25.2 23.6 - 26.8 24.8 23.1 - 26.5 23.9 20.0 - 27.8 27.6 26.0 - 29.1 26.5 24.8 - 28.1 26.9 23.0 - 30.8
MIDWEST
East North Central
Michigan 1 47.3 45.1 - 49.6 47.1 44.5 - 49.7 44.9 40.1 - 49.7 50.8 49.1 - 52.4 50.5 48.6 - 52.4 49.8 46.0 - 53.7
(NPCR) 3 29.4 27.2 - 31.5 28.4 25.9 - 30.8 30.7 25.9 - 35.4 31.6 29.8 - 33.4 31.0 29.0 - 33.0 30.4 26.3 - 34.5
5 24.9 22.7 - 27.1 24.1 21.7 - 26.6 25.0 20.3 - 29.6 27.3 25.2 - 29.3 25.8 23.4 - 28.1 28.3 23.7 - 32.9
Ohio 1 47.7 45.5 - 50.0 46.4 44.0 - 48.9 49.3 43.8 - 54.7 50.4 48.8 - 52.0 49.1 47.3 - 50.9 54.3 50.3 - 58.3
(NPCR) 3 28.6 26.5 - 30.8 27.1 24.7 - 29.4 30.9 25.8 - 36.1 29.4 27.7 - 31.1 27.9 26.0 - 29.7 33.3 28.8 - 37.8
5 25.2 23.1 - 27.4 24.1 21.8 - 26.5 24.6 19.6 - 29.7 24.5 22.5 - 26.5 22.8 20.6 - 25.0 29.8 24.8 - 34.9
Wisconsin 1 56.7 53.3 - 60.0 57.3 53.8 - 60.8 55.5 39.8 - 71.2 57.6 54.9 - 60.2 58.4 55.6 - 61.2 47.6 38.2 - 56.9
(NPCR) 3 32.8 29.4 - 36.1 33.0 29.4 - 36.5 34.5 19.3 - 49.6 33.2 30.2 - 36.2 33.3 30.2 - 36.5 28.6 18.9 - 38.2
5 25.4 22.0 - 28.7 25.3 21.8 - 28.8 30.7 14.6 - 46.8 26.7 23.0 - 30.3 27.1 23.3 - 30.9 18.3 9.6 - 27.0
West North Central
Iowa 1 42.0 37.6 - 46.5 41.3 36.7 - 45.8 60.4 36.2 - 84.5 49.3 46.1 - 52.5 49.2 45.9 - 52.5 48.3 28.7 - 68.0
(SEER) 3 27.1 23.0 - 31.3 26.7 22.4 - 30.9 33.8 11.0 - 56.6 30.0 26.6 - 33.4 29.9 26.4 - 33.3 34.9 13.4 - 56.3
5 20.0 16.1 - 23.9 19.7 15.7 - 23.7 20.6 1.7 - 39.6 24.6 20.6 - 28.7 24.7 20.6 - 28.8 25.4 3.2 - 47.6
Nebraska 1 47.1 41.4 - 52.8 48.1 42.0 - 54.1 46.8 20.7 - 72.9 53.9 49.9 - 57.8 55.2 51.0 - 59.3 31.5 13.2 - 49.8
(NPCR) 3 25.8 20.7 - 30.9 26.8 21.4 - 32.2 23.6 2.3 - 44.8 31.7 27.3 - 36.0 31.9 27.3 - 36.4 25.5 7.5 - 43.4
5 20.4 15.6 - 25.2 20.6 15.6 - 25.7 23.6 2.3 - 44.8 24.9 19.9 - 30.0 25.3 20.1 - 30.6 13.4 0.0 - 29.5
WEST
Mountain
Colorado 1 50.7 46.7 - 54.8 50.2 45.9 - 54.5 43.9 25.8 - 62.0 51.6 48.8 - 54.5 51.3 48.3 - 54.3 49.8 35.8 - 63.8
(NPCR) 3 30.0 26.2 - 33.8 28.6 24.6 - 32.6 30.0 12.8 - 47.1 33.4 30.3 - 36.5 32.5 29.2 - 35.7 30.2 16.8 - 43.6
5 25.7 21.9 - 29.5 24.0 20.1 - 28.0 27.9 10.3 - 45.5 24.0 20.2 - 27.8 22.9 19.0 - 26.8 13.5 0.8 - 26.2
Idaho 1 49.0 42.1 - 55.9 49.2 42.2 - 56.2 - 48.2 43.0 - 53.3 48.5 43.2 - 53.8 -
(NPCR) 3 30.3 23.7 - 36.8 30.4 23.7 - 37.0 - 28.1 22.9 - 33.4 28.0 22.6 - 33.3 -
5 26.3 19.9 - 32.6 26.8 20.3 - 33.3 - 26.8 21.0 - 32.6 26.5 20.5 - 32.5 -
Montana 1 42.2 35.4 - 49.0 42.6 35.7 - 49.6 - 49.8 44.1 - 55.6 49.6 43.8 - 55.3 -
(NPCR) 3 25.6 19.3 - 31.8 26.3 19.9 - 32.8 - 29.2 23.3 - 35.2 28.8 22.7 - 34.8 -
5 19.6 13.9 - 25.4 20.2 14.2 - 26.2 - 25.8 19.5 - 32.1 24.9 18.5 - 31.3 -
New Mexico 1 45.5 40.3 - 50.7 45.7 40.1 - 51.4 - 45.5 41.9 - 49.0 45.8 42.0 - 49.6 28.9 5.9 - 51.9
(SEER) 3 25.9 21.1 - 30.6 26.2 21.0 - 31.3 - 28.1 24.5 - 31.8 29.1 25.2 - 33.1 19.5 0.0 - 39.5
5 22.0 17.3 - 26.7 22.7 17.6 - 27.9 - 25.6 21.5 - 29.7 26.2 21.7 - 30.7 -
Utah 1 48.8 42.7 - 54.9 49.5 43.2 - 55.8 - 49.3 44.8 - 53.8 48.2 43.6 - 52.9 -
(SEER) 3 35.2 29.1 - 41.2 35.4 29.2 - 41.7 - 32.2 27.3 - 37.0 31.4 26.5 - 36.4 -
5 32.5 26.2 - 38.8 32.4 25.9 - 38.9 - 27.5 21.7 - 33.2 25.6 20.2 - 31.0 -
Wyoming 1 39.7 27.7 - 51.7 38.8 26.7 - 50.8 - 46.3 38.8 - 53.7 46.1 38.7 - 53.5 -
(NPCR) 3 25.7 14.6 - 36.7 24.5 13.5 - 35.5 - 28.0 19.8 - 36.2 28.7 20.4 - 37.0 -
5 23.7 12.1 - 35.2 22.5 11.0 - 33.9 - 25.6 16.8 - 34.4 26.2 17.3 - 35.1 -
Pacific
Alaska 1 45.4 35.6 - 55.1 43.7 31.0 - 56.3 - 44.9 37.7 - 52.2 46.7 37.2 - 56.3 -
(NPCR) 3 27.8 19.4 - 36.2 25.6 15.0 - 36.1 - 26.2 18.9 - 33.5 31.3 21.6 - 41.0 -
5 24.7 16.6 - 32.8 21.5 11.7 - 31.2 - 27.4 19.7 - 35.1 32.0 22.0 - 41.9 -
California 1 47.9 46.7 - 49.1 45.4 44.0 - 46.8 42.9 38.8 - 47.0 51.9 51.0 - 52.7 49.3 48.3 - 50.3 47.8 44.7 - 50.9
(NPCR/SEER) 3 28.5 27.4 - 29.6 26.4 25.1 - 27.7 22.1 18.5 - 25.6 32.3 31.4 - 33.2 29.3 28.2 - 30.4 31.8 28.4 - 35.1
5 24.0 22.9 - 25.2 21.7 20.4 - 23.0 18.6 15.1 - 22.1 26.8 25.7 - 27.9 24.0 22.7 - 25.2 26.1 22.3 - 29.9
Hawaii 1 54.8 49.7 - 59.9 48.9 37.1 - 60.8 - 55.6 52.1 - 59.2 56.6 48.3 - 65.0 -
(SEER) 3 35.7 30.6 - 40.7 28.1 17.2 - 39.1 - 36.2 32.2 - 40.2 31.1 22.5 - 39.7 -
5 31.8 26.8 - 36.8 30.4 17.9 - 42.8 - 32.4 27.9 - 36.9 25.3 16.9 - 33.7 -
Oregon 1 45.7 41.5 - 49.8 44.6 40.2 - 49.0 31.2 7.4 - 55.0 50.2 47.2 - 53.2 49.3 46.1 - 52.5 66.9 48.2 - 85.5
(NPCR) 3 27.7 23.8 - 31.6 25.9 21.8 - 29.9 16.1 0.0 - 33.9 33.4 30.1 - 36.7 33.1 29.6 - 36.6 32.1 11.3 - 52.9
5 23.0 19.1 - 26.9 21.5 17.5 - 25.5 8.6 0.0 - 21.1 27.9 24.2 - 31.6 27.5 23.6 - 31.4 33.9 11.9 - 55.9
Washington 1 51.5 48.5 - 54.6 50.8 47.5 - 54.2 38.0 19.9 - 56.0 53.1 50.8 - 55.4 52.1 49.5 - 54.6 59.3 48.7 - 69.8
(NPCR) 3 31.5 28.6 - 34.5 31.1 27.8 - 34.3 19.7 5.0 - 34.4 33.4 30.9 - 35.8 31.4 28.7 - 34.0 41.4 29.0 - 53.7
5 26.3 23.4 - 29.2 25.9 22.7 - 29.1 17.0 2.7 - 31.3 27.5 24.5 - 30.4 25.7 22.5 - 28.9 40.1 26.6 - 53.5
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NS 
(%)
NS 
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NS 
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UNITED STATES
All stages 26.1 25.7 - 26.6 24.9 24.4 - 25.4 26.1 25.0 - 27.3 29.0 28.6 - 29.5 28.0 27.5 - 28.5 28.3 27.1 - 29.4
Localized 60.9 59.8 - 62.0 60.0 58.7 - 61.3 58.1 55.1 - 61.1 64.0 62.9 - 65.0 63.0 61.8 - 64.2 61.1 58.4 - 63.8
Regional 25.2 24.4 - 26.0 23.5 22.6 - 24.4 27.0 24.9 - 29.1 28.2 27.4 - 29.0 26.9 26.0 - 27.9 28.3 26.0 - 30.5
Distant 4.8 4.4 - 5.1 4.5 4.1 - 4.9 4.8 3.8 - 5.8 5.3 4.9 - 5.7 5.0 4.6 - 5.5 5.8 4.8 - 6.7
Unknown 24.4 23.2 - 25.5 22.7 21.4 - 24.0 24.0 21.4 - 26.7 27.9 26.8 - 29.0 27.2 25.9 - 28.6 25.3 22.9 - 27.6
NORTHEAST
New England
Connecticut All stages 30.7 27.2 - 34.2 30.3 26.6 - 34.1 23.0 14.9 - 31.1 32.3 29.0 - 35.5 31.2 27.7 - 34.6 34.6 26.7 - 42.5
(SEER) Localized 73.0 66.0 - 80.1 72.7 65.1 - 80.3 70.2 49.8 - 90.6 69.1 62.4 - 75.7 67.2 59.8 - 74.5 66.1 46.8 - 85.3
Regional 26.5 21.1 - 31.9 26.7 20.8 - 32.5 15.6 2.5 - 28.7 30.0 24.7 - 35.3 29.7 24.1 - 35.4 31.6 16.9 - 46.3
Distant 4.6 2.1 - 7.1 4.9 2.1 - 7.7 0.1 0.0 - 0.2 5.8 3.2 - 8.4 5.4 2.7 - 8.1 8.4 0.5 - 16.4
Unknown 17.9 9.4 - 26.4 15.5 6.8 - 24.1 - 36.3 27.3 - 45.3 34.4 25.0 - 43.7 40.6 18.0 - 63.2
Massachusetts All stages 29.3 26.7 - 31.9 28.9 26.1 - 31.7 34.8 24.5 - 45.1 35.6 32.9 - 38.2 34.9 32.1 - 37.8 29.6 21.5 - 37.8
(NPCR) Localized 70.8 64.9 - 76.8 69.9 63.5 - 76.2 81.0 56.6 - 100.0 77.8 72.5 - 83.1 77.5 71.9 - 83.1 88.4 71.8 - 100.0
Regional 28.9 24.5 - 33.3 28.3 23.7 - 33.0 27.9 10.9 - 44.9 36.0 31.4 - 40.7 35.0 29.9 - 40.0 26.1 11.2 - 40.9
Distant 6.1 4.0 - 8.2 5.5 3.3 - 7.6 15.3 3.8 - 26.7 6.0 3.9 - 8.1 6.3 4.1 - 8.5 5.7 0.0 - 12.8
Unknown 15.3 9.6 - 21.1 15.5 9.6 - 21.5 - 28.5 20.2 - 36.8 24.7 16.0 - 33.4 2.0 0.0 - 6.6
New Hampshire All stages 21.7 15.8 - 27.6 20.8 14.9 - 26.7 - 29.9 24.0 - 35.8 28.6 22.7 - 34.6 -
(NPCR) Localized 53.3 36.2 - 70.5 53.5 35.4 - 71.6 - 62.9 44.6 - 81.2 61.7 43.0 - 80.5 -
Regional 16.2 8.0 - 24.4 15.1 7.2 - 23.0 - 25.1 15.5 - 34.7 24.1 14.7 - 33.4 -
Distant 3.7 0.0 - 8.0 3.7 0.0 - 8.0 - 4.9 1.3 - 8.6 3.1 0.0 - 6.8 -
Unknown 20.2 5.4 - 35.1 21.4 5.9 - 36.9 - 23.8 9.1 - 38.5 20.4 6.2 - 34.5 -
Rhode Island All stages 27.5 21.9 - 33.1 27.7 21.8 - 33.5 29.4 6.3 - 52.5 31.3 25.3 - 37.3 30.8 24.6 - 37.0 34.7 13.7 - 55.7
(NPCR) Localized 74.5 59.4 - 89.5 70.6 55.3 - 85.8 - - - -
Regional 17.4 8.4 - 26.3 18.3 8.9 - 27.8 - - - -
Distant 5.8 1.5 - 10.1 4.9 0.9 - 8.8 - - - -
Unknown 13.4 3.4 - 23.4 14.0 3.6 - 24.4 - - - -
Mid Atlantic
New Jersey All stages 27.9 25.9 - 30.0 26.7 24.4 - 29.0 27.2 21.9 - 32.6 29.3 27.2 - 31.4 28.9 26.5 - 31.3 25.4 20.3 - 30.5
(NPCR/SEER) Localized 61.1 56.3 - 65.8 59.1 53.7 - 64.5 56.2 43.7 - 68.8 66.4 61.5 - 71.4 68.2 62.7 - 73.8 52.1 40.7 - 63.4
Regional 26.1 22.7 - 29.6 26.6 22.6 - 30.5 23.5 15.2 - 31.7 27.6 23.9 - 31.3 26.7 22.4 - 31.0 21.2 13.7 - 28.7
Distant 3.3 1.9 - 4.6 3.1 1.6 - 4.5 1.6 0.0 - 4.0 3.5 2.1 - 4.9 3.4 1.9 - 4.9 3.1 0.0 - 6.4
Unknown 30.7 24.9 - 36.5 26.5 20.5 - 32.5 17.1 5.1 - 29.1 31.9 25.5 - 38.4 27.5 19.9 - 35.1 29.0 15.9 - 42.2
New York All stages 30.6 29.2 - 31.9 28.4 26.8 - 30.0 30.9 27.6 - 34.2 34.6 33.2 - 36.0 32.3 30.6 - 34.0 32.6 29.5 - 35.6
(NPCR) Localized 65.2 61.9 - 68.5 64.1 60.3 - 68.0 64.1 56.1 - 72.1 72.1 69.0 - 75.2 70.0 66.2 - 73.9 67.6 61.4 - 73.7
Regional 30.0 27.6 - 32.4 27.1 24.4 - 29.8 32.1 26.2 - 37.9 33.3 30.8 - 35.8 31.3 28.4 - 34.3 31.8 25.7 - 37.8
Distant 8.9 7.3 - 10.5 7.7 6.0 - 9.4 8.8 5.2 - 12.4 8.1 6.8 - 9.4 7.1 5.6 - 8.5 9.1 6.3 - 11.9
Unknown 26.7 23.6 - 29.7 23.0 19.5 - 26.5 28.3 21.4 - 35.3 35.6 32.0 - 39.2 33.0 28.8 - 37.3 35.3 27.9 - 42.8
Pennsylvania All stages 23.8 22.1 - 25.6 23.2 21.3 - 25.1 23.6 18.7 - 28.6 28.1 26.2 - 29.9 26.9 24.9 - 28.9 33.5 28.3 - 38.7
(NPCR) Localized 63.4 58.9 - 67.8 62.6 57.9 - 67.4 60.9 45.7 - 76.2 66.4 62.0 - 70.9 66.3 61.6 - 71.1 67.6 56.8 - 78.4
Regional 21.0 18.3 - 23.7 20.3 17.5 - 23.2 19.4 12.1 - 26.7 26.4 23.2 - 29.7 26.2 22.7 - 29.7 33.1 24.4 - 41.8
Distant 2.9 1.7 - 4.0 2.7 1.5 - 3.9 3.9 1.3 - 6.5 3.9 2.6 - 5.2 3.0 1.8 - 4.3 9.8 5.0 - 14.7
Unknown 22.6 17.4 - 27.8 19.9 14.2 - 25.6 19.8 8.5 - 31.0 25.6 19.7 - 31.6 23.9 18.2 - 29.6 13.0 3.3 - 22.7
SOUTH
South Atlantic
Delaware All stages 30.7 23.1 - 38.2 30.0 21.6 - 38.5 28.4 12.7 - 44.1 28.8 22.6 - 34.9 28.4 21.6 - 35.1 28.0 13.4 - 42.6
(NPCR) Localized 72.1 53.7 - 90.5 67.3 48.1 - 86.4 75.4 35.0 - 100.0 59.6 41.1 - 78.0 58.3 35.4 - 81.2 58.4 27.7 - 89.1
Regional 22.8 10.8 - 34.7 28.6 12.8 - 44.4 0.0 - 33.8 24.2 - 43.3 38.3 27.3 - 49.3 20.6 1.1 - 40.2
Distant 4.3 0.0 - 9.6 3.1 0.0 - 7.9 7.7 0.0 - 19.1 5.2 0.3 - 10.1 4.5 0.0 - 9.5 7.9 0.0 - 18.6
Unknown 19.3 1.2 - 37.3 11.0 0.0 - 27.0 - 21.5 6.2 - 36.8 11.4 0.0 - 24.1 -
Florida All stages 27.7 26.1 - 29.2 26.9 25.2 - 28.6 30.4 26.3 - 34.5 36.2 34.6 - 37.8 36.6 34.9 - 38.4 31.6 27.2 - 36.0
(NPCR) Localized 61.2 57.3 - 65.0 61.0 56.7 - 65.4 57.3 47.2 - 67.4 70.4 66.8 - 73.9 71.5 67.8 - 75.2 58.9 47.3 - 70.5
Regional 26.5 23.9 - 29.1 25.2 22.3 - 28.0 33.2 26.1 - 40.4 34.0 30.9 - 37.1 33.9 30.6 - 37.3 33.2 25.7 - 40.7
Distant 6.7 5.2 - 8.3 6.7 5.0 - 8.3 6.9 3.4 - 10.4 11.5 9.6 - 13.5 11.4 9.2 - 13.7 10.7 7.0 - 14.3
Unknown 28.6 24.6 - 32.6 26.6 22.3 - 30.9 36.2 26.6 - 45.7 38.6 34.9 - 42.2 40.1 35.9 - 44.2 28.3 20.7 - 36.0
Georgia All stages 24.9 22.4 - 27.5 24.1 20.8 - 27.4 24.6 20.5 - 28.8 28.0 25.5 - 30.4 27.3 24.1 - 30.5 29.5 25.6 - 33.4
(NPCR/SEER) Localized 57.4 51.1 - 63.7 57.1 49.1 - 65.2 56.3 46.8 - 65.9 58.9 53.5 - 64.2 57.5 50.5 - 64.4 61.4 53.7 - 69.2
Regional 21.5 17.4 - 25.7 18.5 13.4 - 23.6 20.5 14.0 - 26.9 24.6 19.9 - 29.3 23.4 17.8 - 29.0 26.9 18.6 - 35.1
Distant 1.7 0.7 - 2.8 1.4 0.2 - 2.6 1.7 0.1 - 3.3 3.3 1.7 - 4.9 3.5 1.5 - 5.4 2.5 0.5 - 4.4
Unknown 28.9 21.8 - 36.0 21.3 12.8 - 29.9 27.7 16.0 - 39.3 29.4 22.4 - 36.5 23.0 14.6 - 31.4 32.1 22.1 - 42.1
Maryland All stages 26.8 23.5 - 30.0 23.8 19.7 - 27.8 25.4 19.7 - 31.1 28.8 25.7 - 31.9 28.2 24.2 - 32.2 26.4 21.2 - 31.6
(NPCR) Localized - - - - - -
Regional - - - - - -
Distant - - - - - -
Unknown - - - - - -
95% CI95% CI 95% CI 95% CI 95% CI 95% CI
2001-2003 2004-2009
All races White Black All races White Black
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Summary 
Stage
NS 
(%)
NS 
(%)
NS 
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NS 
(%)
NS 
(%)
NS 
(%) 95% CI95% CI 95% CI 95% CI 95% CI 95% CI
2001-2003 2004-2009
All races White Black All races White Black
North Carolina All stages 25.6 23.0 - 28.1 25.1 22.1 - 28.2 23.8 19.2 - 28.4 29.2 26.7 - 31.7 29.0 25.9 - 32.1 27.8 23.7 - 31.9
(NPCR) Localized 60.7 54.9 - 66.6 62.5 55.6 - 69.3 54.2 43.6 - 64.9 63.8 58.6 - 69.0 61.3 54.7 - 67.8 66.0 57.0 - 75.0
Regional 21.4 17.1 - 25.6 17.3 12.7 - 21.9 28.5 20.3 - 36.7 26.7 22.1 - 31.4 26.1 20.4 - 31.8 27.4 20.0 - 34.9
Distant 2.2 1.0 - 3.4 1.3 0.2 - 2.4 3.3 0.8 - 5.8 3.9 2.4 - 5.4 4.8 2.7 - 6.9 2.7 1.1 - 4.3
Unknown 30.0 22.7 - 37.4 27.1 18.2 - 35.9 11.3 1.3 - 21.3 30.2 23.4 - 37.0 33.4 24.8 - 42.0 22.7 14.3 - 31.0
South Carolina All stages 25.2 22.0 - 28.5 25.8 21.5 - 30.1 22.5 17.8 - 27.3 26.9 23.7 - 30.1 29.7 25.4 - 34.0 22.0 17.2 - 26.7
(NPCR) Localized 59.1 51.0 - 67.2 65.2 55.1 - 75.2 44.8 33.3 - 56.4 56.6 49.2 - 64.0 57.9 49.0 - 66.9 53.4 42.0 - 64.7
Regional 20.1 15.3 - 24.9 16.8 11.3 - 22.4 24.0 16.0 - 32.0 26.8 21.0 - 32.6 29.7 22.3 - 37.1 22.0 14.8 - 29.3
Distant 5.3 2.5 - 8.1 5.3 1.8 - 8.7 4.7 1.3 - 8.1 4.0 2.2 - 5.8 4.6 2.2 - 7.0 3.8 1.6 - 6.0
Unknown 23.9 15.6 - 32.2 23.5 10.9 - 36.0 15.6 4.5 - 26.7 18.3 11.9 - 24.6 23.1 12.9 - 33.4 13.2 5.2 - 21.1
West Virginia All stages 20.8 16.2 - 25.4 20.5 15.8 - 25.1 23.7 2.3 - 45.0 22.8 18.4 - 27.1 22.9 18.4 - 27.3 23.8 4.5 - 43.0
(NPCR) Localized 41.4 29.8 - 53.0 39.1 27.4 - 50.7 - 58.9 49.2 - 68.6 59.9 50.0 - 69.9 -
Regional 15.3 8.9 - 21.6 15.3 9.0 - 21.7 - 12.5 6.6 - 18.3 11.8 6.2 - 17.5 48.8 14.7 - 83.0
Distant 1.2 0.0 - 3.1 1.3 0.0 - 3.2 - 0.0 0.0 - 0.0 - 0.4 0.0 - 1.4
Unknown 18.3 7.7 - 29.0 19.9 8.4 - 31.4 - 29.5 20.4 - 38.6 31.5 21.8 - 41.1 -
East South Central
Alabama All stages 27.8 24.4 - 31.2 27.1 23.0 - 31.2 29.4 23.5 - 35.2 26.9 23.8 - 30.1 28.4 24.5 - 32.3 24.1 19.0 - 29.2
(NPCR) Localized 58.7 51.2 - 66.1 56.8 48.2 - 65.5 59.9 44.5 - 75.4 53.0 46.3 - 59.7 54.4 46.5 - 62.3 49.9 38.5 - 61.3
Regional 26.6 21.2 - 32.0 21.6 16.1 - 27.1 38.6 28.2 - 49.0 20.6 15.4 - 25.7 20.9 14.8 - 27.1 18.6 11.6 - 25.6
Distant 3.7 1.3 - 6.0 3.9 1.1 - 6.8 3.2 0.0 - 6.6 6.7 4.0 - 9.4 6.4 3.7 - 9.0 7.3 3.8 - 10.7
Unknown 18.4 10.4 - 26.3 19.1 8.6 - 29.6 18.3 6.1 - 30.5 25.8 19.6 - 32.0 16.6 8.2 - 25.0 18.0 2.8 - 33.2
Kentucky All stages 20.7 17.4 - 24.1 21.1 17.6 - 24.6 15.9 5.9 - 25.9 27.8 24.5 - 31.2 27.6 24.1 - 31.1 31.3 23.0 - 39.6
(NPCR/SEER) Localized 45.4 37.5 - 53.4 46.5 38.1 - 54.8 30.4 6.4 - 54.3 65.1 58.0 - 72.1 63.2 55.8 - 70.6 72.8 38.9 - 100.0
Regional 16.5 11.3 - 21.8 15.8 10.4 - 21.3 18.7 3.3 - 34.1 22.5 16.8 - 28.1 22.9 17.0 - 28.7 12.9 0.0 - 29.6
Distant 2.3 0.5 - 4.1 2.0 0.2 - 3.7 6.5 0.0 - 16.2 2.8 1.1 - 4.5 2.8 1.0 - 4.7 4.8 0.0 - 10.5
Unknown 19.8 12.5 - 27.1 20.8 12.9 - 28.6 3.0 0.0 - 9.8 16.9 10.5 - 23.3 17.8 10.9 - 24.7 -
Mississippi All stages 33.6 26.3 - 40.8 33.2 24.2 - 42.1 35.8 24.3 - 47.2 23.8 19.8 - 27.9 23.0 17.6 - 28.4 26.8 21.1 - 32.4
(NPCR) Localized 56.4 41.3 - 71.4 45.2 28.1 - 62.3 80.4 55.8 - 100.0 52.2 43.2 - 61.1 47.3 36.8 - 57.7 65.1 53.4 - 76.8
Regional 27.6 14.9 - 40.4 23.2 7.4 - 39.0 31.3 12.5 - 50.2 18.8 12.6 - 24.9 15.5 8.7 - 22.3 22.0 15.3 - 28.7
Distant 5.5 0.0 - 12.2 0.0 - 9.9 0.0 - 21.5 2.4 0.0 - 5.3 2.8 0.0 - 6.5 5.0 0.8 - 9.1
Unknown 33.7 15.5 - 51.8 49.1 24.3 - 74.0 15.9 0.0 - 35.7 26.0 18.1 - 33.9 31.4 18.7 - 44.1 15.2 8.2 - 22.2
Tennessee All stages 22.4 17.5 - 27.3 19.5 14.4 - 24.6 31.8 15.6 - 48.0 29.7 26.8 - 32.6 30.8 27.6 - 34.1 24.1 17.9 - 30.3
(NPCR) Localized 40.2 27.6 - 52.8 36.5 23.6 - 49.4 58.5 19.3 - 97.7 54.4 47.7 - 61.0 54.5 46.9 - 62.1 51.1 38.1 - 64.1
Regional 19.0 12.2 - 25.9 16.1 8.0 - 24.2 31.7 11.0 - 52.4 27.9 22.8 - 33.0 28.9 23.3 - 34.4 24.4 13.8 - 35.1
Distant 1.6 0.0 - 4.2 1.8 0.0 - 4.7 - 6.1 3.6 - 8.5 6.7 3.9 - 9.6 5.0 0.3 - 9.6
Unknown 18.2 5.5 - 30.9 14.0 2.5 - 25.6 - 30.2 23.0 - 37.4 32.3 24.2 - 40.3 20.6 11.4 - 29.8
West South Central
Louisiana All stages 25.3 22.2 - 28.3 24.5 20.5 - 28.6 24.9 20.4 - 29.5 24.9 22.1 - 27.8 26.3 22.3 - 30.2 23.9 19.9 - 27.9
(NPCR/SEER) Localized 55.2 48.3 - 62.1 59.0 50.1 - 68.0 48.2 38.0 - 58.4 50.4 44.2 - 56.7 51.1 42.9 - 59.2 49.4 40.8 - 58.0
Regional 25.6 20.3 - 30.8 21.2 14.7 - 27.7 28.7 21.0 - 36.5 23.2 17.6 - 28.8 21.2 13.7 - 28.6 26.0 17.9 - 34.1
Distant 5.7 3.2 - 8.3 5.2 2.2 - 8.2 6.1 2.2 - 10.0 3.9 2.1 - 5.7 4.5 2.0 - 6.9 4.2 1.7 - 6.8
Unknown 8.0 2.5 - 13.6 10.7 2.3 - 19.1 3.8 0.0 - 8.3 28.0 20.6 - 35.5 29.2 19.5 - 38.9 21.2 11.1 - 31.4
Oklahoma All stages 19.7 16.2 - 23.2 18.4 14.6 - 22.3 32.3 19.8 - 44.8 22.3 18.7 - 25.9 21.8 17.7 - 25.9 40.9 29.4 - 52.3
(NPCR) Localized 37.7 28.5 - 46.9 35.3 25.1 - 45.6 66.8 41.9 - 91.7 46.7 39.3 - 54.2 46.0 37.9 - 54.2 67.7 44.0 - 91.3
Regional 17.4 11.9 - 22.9 16.4 10.4 - 22.5 23.7 4.1 - 43.2 13.5 7.9 - 19.1 11.6 6.8 - 16.5 51.7 28.6 - 74.7
Distant 4.6 1.7 - 7.4 4.5 1.5 - 7.4 7.7 0.0 - 19.2 4.5 1.8 - 7.2 3.4 0.9 - 5.9 14.2 0.0 - 29.0
Unknown 17.5 9.2 - 25.9 17.1 7.8 - 26.4 26.2 3.2 - 49.1 22.3 15.9 - 28.7 22.6 15.1 - 30.1 21.8 3.4 - 40.2
Texas All stages 25.2 23.6 - 26.8 24.8 23.1 - 26.5 23.9 20.0 - 27.8 27.6 26.0 - 29.1 26.5 24.8 - 28.1 26.9 23.0 - 30.8
(NPCR) Localized 54.4 50.2 - 58.6 53.1 48.5 - 57.8 58.4 47.7 - 69.0 58.6 55.1 - 62.2 57.6 53.6 - 61.6 61.9 53.6 - 70.2
Regional 24.2 21.5 - 26.9 23.3 20.4 - 26.2 25.2 18.5 - 32.0 27.4 24.7 - 30.2 24.8 21.8 - 27.8 31.6 23.7 - 39.5
Distant 6.3 4.8 - 7.8 6.6 4.9 - 8.3 4.8 2.1 - 7.6 5.3 4.0 - 6.6 5.0 3.6 - 6.3 3.6 1.5 - 5.7
Unknown 27.8 24.1 - 31.6 28.0 23.8 - 32.2 19.1 11.7 - 26.5 28.9 24.9 - 32.9 26.8 22.3 - 31.2 26.5 18.8 - 34.3
MIDWEST
East North Central
Michigan All stages 24.9 22.7 - 27.1 24.1 21.7 - 26.6 25.0 20.3 - 29.6 27.3 25.2 - 29.3 25.8 23.4 - 28.1 28.3 23.7 - 32.9
(NPCR) Localized 58.6 53.4 - 63.8 59.5 53.5 - 65.4 53.6 43.3 - 64.0 60.4 55.4 - 65.4 59.5 53.8 - 65.2 60.0 49.1 - 70.8
Regional 23.4 19.7 - 27.2 22.1 18.0 - 26.3 24.1 16.7 - 31.5 25.2 20.9 - 29.4 23.7 19.2 - 28.2 29.0 19.8 - 38.2
Distant 4.3 2.6 - 5.9 4.2 2.3 - 6.1 5.0 2.1 - 8.0 4.9 3.0 - 6.7 4.3 2.5 - 6.2 6.1 2.3 - 9.9
Unknown 17.7 12.8 - 22.5 16.5 11.2 - 21.7 16.5 6.5 - 26.4 24.7 20.9 - 28.5 22.1 17.9 - 26.3 26.2 18.6 - 33.9
Ohio All stages 25.2 23.1 - 27.4 24.1 21.8 - 26.5 24.6 19.6 - 29.7 24.5 22.5 - 26.5 22.8 20.6 - 25.0 29.8 24.8 - 34.9
(NPCR) Localized 58.6 53.0 - 64.3 57.0 50.7 - 63.2 60.6 45.3 - 75.8 61.4 55.7 - 67.1 59.4 53.3 - 65.5 69.5 58.0 - 81.0
Regional 21.5 17.9 - 25.1 20.7 16.7 - 24.6 22.9 14.8 - 30.9 23.4 19.8 - 27.0 21.7 17.9 - 25.4 34.5 25.4 - 43.6
Distant 6.0 3.9 - 8.1 6.0 3.8 - 8.2 4.6 0.3 - 8.9 5.2 3.5 - 6.9 4.9 3.2 - 6.7 6.8 3.0 - 10.5
Unknown 23.6 19.1 - 28.0 21.1 16.3 - 25.8 23.9 13.3 - 34.6 21.5 17.0 - 25.9 19.7 15.2 - 24.2 14.8 5.4 - 24.3
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SEER 
Summary 
Stage
NS 
(%)
NS 
(%)
NS 
(%)
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(%)
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(%)
NS 
(%) 95% CI95% CI 95% CI 95% CI 95% CI 95% CI
2001-2003 2004-2009
All races White Black All races White Black
Wisconsin All stages 25.4 22.0 - 28.7 25.3 21.8 - 28.8 30.7 14.6 - 46.8 26.7 23.0 - 30.3 27.1 23.3 - 30.9 18.3 9.6 - 27.0
(NPCR) Localized - - - - - -
Regional - - - - - -
Distant - - - - - -
Unknown - - - - - -
West North Central
Iowa All stages 20.0 16.1 - 23.9 19.7 15.7 - 23.7 20.6 1.7 - 39.6 24.6 20.6 - 28.7 24.7 20.6 - 28.8 25.4 3.2 - 47.6
(SEER) Localized 53.9 43.6 - 64.1 54.4 43.8 - 65.0 - 60.2 50.7 - 69.6 59.5 49.9 - 69.0 -
Regional 24.8 17.4 - 32.3 24.2 16.7 - 31.7 - 28.1 21.3 - 34.9 28.6 21.7 - 35.6 16.9 0.0 - 39.4
Distant 1.1 0.0 - 2.4 1.3 0.0 - 2.6 - 3.2 0.9 - 5.5 3.2 0.9 - 5.5 -
Unknown 7.9 0.6 - 15.3 7.0 0.0 - 14.2 - 14.0 5.4 - 22.6 13.3 4.8 - 21.9 -
Nebraska All stages 20.4 15.6 - 25.2 20.6 15.6 - 25.7 23.6 2.3 - 44.8 24.9 19.9 - 30.0 25.3 20.1 - 30.6 13.4 0.0 - 29.5
(NPCR) Localized 50.6 35.5 - 65.7 50.5 34.8 - 66.1 - 64.4 50.7 - 78.0 64.6 50.7 - 78.5 -
Regional 17.7 10.5 - 24.8 18.4 11.0 - 25.9 - 19.8 12.9 - 26.8 20.2 13.0 - 27.4 -
Distant 3.9 0.0 - 7.7 4.1 0.0 - 8.2 - 9.5 5.3 - 13.6 9.2 5.2 - 13.3 35.4 6.5 - 64.2
Unknown 13.2 4.2 - 22.3 12.8 3.4 - 22.1 - 25.7 14.1 - 37.3 29.0 16.4 - 41.5 -
WEST
Mountain
Colorado All stages 25.7 21.9 - 29.5 24.0 20.1 - 28.0 27.9 10.3 - 45.5 24.0 20.2 - 27.8 22.9 19.0 - 26.8 13.5 0.8 - 26.2
(NPCR) Localized 58.1 48.7 - 67.5 57.9 48.0 - 67.7 - 45.6 35.3 - 55.8 44.6 33.8 - 55.3 54.4 14.9 - 93.9
Regional 23.3 16.8 - 29.8 20.6 14.2 - 27.1 - 29.0 21.8 - 36.2 27.7 20.0 - 35.4 10.6 0.0 - 25.9
Distant 7.2 3.7 - 10.7 6.8 3.2 - 10.3 0.0 - 8.4 5.3 - 11.5 8.0 5.1 - 11.0 0.0 0.0 - 0.1
Unknown 17.2 8.8 - 25.5 11.9 4.3 - 19.5 - 24.9 16.2 - 33.6 22.8 13.9 - 31.8 -
Idaho All stages 26.3 19.9 - 32.6 26.8 20.3 - 33.3 - 26.8 21.0 - 32.6 26.5 20.5 - 32.5 -
(NPCR) Localized 62.2 45.6 - 78.8 62.2 45.6 - 78.8 - 86.8 74.0 - 99.7 88.3 75.2 - 100.0 -
Regional 32.3 22.0 - 42.7 34.8 22.4 - 47.2 - 25.5 15.8 - 35.3 25.3 15.6 - 35.0 -
Distant 0.0 0.0 - 0.0 0.0 0.0 - 0.0 - 4.7 0.6 - 8.7 3.8 0.1 - 7.6 -
Unknown 4.1 0.0 - 9.6 4.1 0.0 - 9.6 - 13.2 2.7 - 23.6 10.5 0.9 - 20.1 -
Montana All stages 19.6 13.9 - 25.4 20.2 14.2 - 26.2 - 25.8 19.5 - 32.1 24.9 18.5 - 31.3 -
(NPCR) Localized 54.5 36.5 - 72.5 55.8 37.5 - 74.1 - 50.5 30.2 - 70.9 48.4 26.2 - 70.6 -
Regional 13.6 5.6 - 21.7 13.6 5.1 - 22.0 - 21.3 13.0 - 29.7 24.1 15.1 - 33.1 -
Distant 0.0 0.0 - 0.0 0.0 0.0 - 0.0 - 4.1 0.0 - 8.2 1.8 0.0 - 4.5 -
Unknown 24.9 5.9 - 43.8 24.9 5.9 - 43.8 - 33.1 10.2 - 56.0 32.0 7.4 - 56.6 -
New Mexico All stages 22.0 17.3 - 26.7 22.7 17.6 - 27.9 - 25.6 21.5 - 29.7 26.2 21.7 - 30.7 -
(SEER) Localized 38.3 26.4 - 50.2 39.4 26.5 - 52.2 - 48.1 39.2 - 57.0 46.9 37.3 - 56.4 -
Regional 25.8 17.6 - 34.0 26.4 17.4 - 35.4 - 24.5 17.5 - 31.5 24.5 17.2 - 31.8 -
Distant 2.8 0.2 - 5.4 3.2 0.2 - 6.2 - 4.8 1.2 - 8.3 4.3 0.4 - 8.3 -
Unknown 10.2 0.4 - 20.0 11.5 0.5 - 22.5 - 19.3 9.0 - 29.6 21.9 10.5 - 33.2 -
Utah All stages 32.5 26.2 - 38.8 32.4 25.9 - 38.9 - 27.5 21.7 - 33.2 25.6 20.2 - 31.0 -
(SEER) Localized 68.7 57.9 - 79.5 69.4 56.3 - 82.6 - 67.4 56.3 - 78.6 67.7 57.1 - 78.2 -
Regional 26.1 15.7 - 36.4 27.1 14.5 - 39.7 - 26.2 16.0 - 36.3 21.9 12.1 - 31.8 -
Distant 3.2 0.0 - 6.6 3.6 0.0 - 7.5 - 3.0 0.0 - 6.6 3.2 0.0 - 7.2 -
Unknown 8.9 0.0 - 19.8 8.9 0.0 - 19.8 - 3.7 0.0 - 9.3 4.2 0.0 - 10.5 -
Wyoming All stages 23.7 12.1 - 35.2 22.5 11.0 - 33.9 - 25.6 16.8 - 34.4 26.2 17.3 - 35.1 -
(NPCR) Localized 47.5 17.2 - 77.8 42.1 11.2 - 73.0 - 45.2 21.4 - 69.1 45.2 21.4 - 69.1 -
Regional 30.6 7.0 - 54.2 30.6 7.0 - 54.2 - 30.7 11.9 - 49.5 30.8 11.9 - 49.7 -
Distant 6.3 0.0 - 15.9 6.3 0.0 - 15.9 - 4.0 0.0 - 9.7 4.0 0.0 - 9.7 -
Unknown 16.1 0.7 - 31.4 16.1 0.7 - 31.4 - 21.7 3.2 - 40.2 22.5 3.3 - 41.7 -
Pacific
Alaska All stages 24.7 16.6 - 32.8 21.5 11.7 - 31.2 - 27.4 19.7 - 35.1 32.0 22.0 - 41.9 -
(NPCR) Localized 68.3 43.9 - 92.6 - - 60.6 42.1 - 79.0 63.4 39.5 - 87.4 -
Regional 24.7 10.1 - 39.4 17.7 0.9 - 34.5 - 30.3 16.8 - 43.8 38.2 18.1 - 58.3 -
Distant 3.1 0.0 - 7.8 6.3 0.0 - 15.8 - 6.2 0.1 - 12.3 10.9 0.0 - 23.2 -
Unknown 30.0 4.1 - 55.9 32.0 1.5 - 62.4 - 20.8 2.4 - 39.1 19.1 0.0 - 40.0 -
California All stages 24.0 22.9 - 25.2 21.7 20.4 - 23.0 18.6 15.1 - 22.1 26.8 25.7 - 27.9 24.0 22.7 - 25.2 26.1 22.3 - 29.9
(NPCR/SEER) Localized 63.0 60.1 - 65.8 59.2 55.7 - 62.6 46.6 35.3 - 58.0 64.4 61.9 - 67.0 61.5 58.6 - 64.4 55.6 46.0 - 65.2
Regional 27.4 25.3 - 29.4 25.2 22.9 - 27.6 23.9 17.1 - 30.8 29.1 26.9 - 31.2 25.8 23.3 - 28.4 27.6 21.0 - 34.2
Distant 3.6 2.8 - 4.4 3.3 2.5 - 4.2 1.8 0.4 - 3.3 4.3 3.4 - 5.2 3.7 2.7 - 4.7 8.1 4.7 - 11.5
Unknown 16.3 13.0 - 19.6 12.8 9.4 - 16.3 9.5 3.0 - 16.0 17.7 14.4 - 20.9 17.0 13.2 - 20.8 6.8 0.7 - 13.0
Hawaii All stages 31.8 26.8 - 36.8 30.4 17.9 - 42.8 - 32.4 27.9 - 36.9 25.3 16.9 - 33.7 -
(SEER) Localized 74.5 66.6 - 82.5 84.7 54.0 - 100.0 - 77.4 69.5 - 85.4 45.3 7.6 - 83.1 -
Regional 29.6 22.3 - 37.0 15.7 2.3 - 29.1 - 31.1 23.4 - 38.8 17.1 2.7 - 31.4 -
Distant 2.5 0.4 - 4.7 8.6 0.0 - 18.6 - 1.9 0.0 - 4.3 5.4 0.0 - 12.8 -
Unknown 12.7 0.0 - 26.6 - - 22.7 7.9 - 37.5 12.1 0.0 - 30.1 -
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Stage
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(%) 95% CI95% CI 95% CI 95% CI 95% CI 95% CI
2001-2003 2004-2009
All races White Black All races White Black
Oregon All stages 23.0 19.1 - 26.9 21.5 17.5 - 25.5 8.6 0.0 - 21.1 27.9 24.2 - 31.6 27.5 23.6 - 31.4 33.9 11.9 - 55.9
(NPCR) Localized 63.8 53.4 - 74.2 60.2 48.8 - 71.6 - 74.0 66.2 - 81.8 73.3 65.2 - 81.4 -
Regional 23.9 17.6 - 30.1 22.6 16.0 - 29.2 - 28.5 22.0 - 35.0 25.9 19.1 - 32.7 -
Distant 4.6 2.0 - 7.3 5.0 2.1 - 7.9 - 3.4 1.7 - 5.2 3.4 1.6 - 5.3 -
Unknown 6.3 0.3 - 12.3 6.8 0.3 - 13.2 - 5.4 0.2 - 10.6 6.5 0.6 - 12.5 -
Washington All stages 26.3 23.4 - 29.2 25.9 22.7 - 29.1 17.0 2.7 - 31.3 27.5 24.5 - 30.4 25.7 22.5 - 28.9 40.1 26.6 - 53.5
(NPCR) Localized 63.8 56.8 - 70.7 64.4 57.0 - 71.8 - 72.0 64.7 - 79.2 69.7 61.6 - 77.8 83.9 62.5 - 100.0
Regional 27.4 22.4 - 32.4 25.5 20.5 - 30.5 - 27.7 22.3 - 33.1 25.1 19.4 - 30.7 34.0 5.6 - 62.5
Distant 1.0 0.1 - 1.9 1.4 0.2 - 2.6 - 3.7 2.0 - 5.3 2.5 1.1 - 3.9 17.2 2.9 - 31.4
Unknown 13.2 7.0 - 19.4 9.3 3.5 - 15.0 - 26.6 18.0 - 35.2 27.7 18.7 - 36.7 -
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